EUVIMEDEUVIMED entdecken
Crossref

Astaxanthin and omega-3 fatty acids enhance endometrial receptivity in a rat model of polycystic ovary syndrome

Tuğba Bal Taştan, Jale Selli, Erdem Toktay, Hilal Üstündağ, Rüstem Anıl Ugan

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04808-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Tuğba Bal Taştan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Histology and Embryology, Erzincan Binali Yıldırım University, Erzincan, Türkiye. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Fatty Acids, Omega-3, Endometrium, Antioxidants. Die Arbeit nennt 65 Literaturangaben. Gefördert von: Atatürk Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) adversely affects endometrial receptivity and fertility outcomes. This study investigated whether combining high-dose antioxidants (astaxanthin or omega-3 fatty acids) with metformin improves endometrial receptivity markers, reduces oxidative stress, and normalizes hormone profiles in a PCOS rat model compared to metformin alone or no treatment. Fifty-six female Sprague-Dawley rats (200-250g) were divided into seven groups: Control, PCOS, PCOS + Met, and groups receiving metformin plus either astaxanthin (PCOS + Met + AX5 or PCOS + Met + AX10) or omega-3 (PCOS + Met + OMG400 or PCOS + Met + OMG1000). PCOS was induced using letrozole for 21 days, followed by one week of treatment. After establishing endometrial receptivity, uterine tissues were analyzed histopathologically, immunohistochemically, and biochemically on day 5. The PCOS group demonstrated significant increases in body weight and oxidative stress markers (malondialdehyde) compared to controls (p < 0.001). High-dose antioxidant supplementation (PCOS + Met + AX10 and PCOS + Met + OMG1000) significantly improved these parameters (p < 0.001). Immunohistochemically, integrin β3 expression increased while mucin 1 (MUC-1) decreased in high-dose groups compared to PCOS (p < 0.001). The LH:FSH ratio normalized to control levels in PCOS + Met + AX10 and PCOS + Met + OMG1000 groups. Histological examination revealed enhanced endometrial morphology and increased pinopode-like structure formation in antioxidant-supplemented groups. High-dose astaxanthin and omega-3 fatty acid supplementation, combined with metformin, may enhance endometrial receptivity in PCOS by reducing oxidative stress and modulating key implantation markers. This therapeutic approach could potentially improve fertility outcomes in women with PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeFatty Acids, Omega-3EndometriumAntioxidantsAnimalsFemaleRats, Sprague-DawleyXanthophyllsDisease Models, AnimalMetforminOxidative StressRats

Stichwörter der Autor:innen

AstaxanthinEndometrial receptivityOmega-3Oxidative stressPolycystic ovary syndrome

Substanzen

astaxanthineFatty Acids, Omega-3XanthophyllsMetforminAntioxidants

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Histology and Embryology, Erzincan Binali Yıldırım University, Erzincan, Türkiye.
  • Faculty of Medicine, Department of Histology and Embryology, Alanya Alaaddin Keykubat University, Alanya, Türkiye.
  • Faculty of Medicine, Department of Histology and Embryology, Kafkas University, Kars, Türkiye.
  • Faculty of Medicine, Department of Physiology, Erzincan Binali Yıldırım University, Erzincan, Türkiye. hilal.ustundag@erzincan.edu.tr.
  • Faculty of Pharmacy, Department of Pharmacology, Atatürk University, Erzurum, Türkiye.

Förderung

  • Atatürk Üniversitesi

Zitieren

APA

Bal Taştan, T., Selli, J., Toktay, E., Üstündağ, H., & Ugan, R. A. (2025). Astaxanthin and omega-3 fatty acids enhance endometrial receptivity in a rat model of polycystic ovary syndrome. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04808-2

Vancouver

Bal Taştan T, Selli J, Toktay E, Üstündağ H, Ugan RA. Astaxanthin and omega-3 fatty acids enhance endometrial receptivity in a rat model of polycystic ovary syndrome. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04808-2

BibTeX
@article{BalTatan2025,
  author = {Bal Taştan, Tuğba and Selli, Jale and Toktay, Erdem and Üstündağ, Hilal and Ugan, Rüstem Anıl},
  title = {Astaxanthin and omega-3 fatty acids enhance endometrial receptivity in a rat model of polycystic ovary syndrome},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04808-2}
}
Kostenlos starten →